Le Lézard
Classified in: Covid-19 virus
Subject: Product/Service

AM Best Affirms Credit Ratings of CNO Financial Group, Inc. and Its Life/Health Subsidiaries


AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) of the life/health insurance subsidiaries of CNO Financial Group, Inc. (headquartered in Carmel, IN) [NYSE: CNO]. These subsidiaries are referred to collectively as CNO Financial Group (CNO). Concurrently, AM Best has affirmed the Long-Term ICR of "bbb" (Good) and the Long-Term Issue Credit Ratings (Long-Term IR) of CNO Financial Group, Inc. The outlook of these Credit Ratings (ratings) is stable. (See below for a detailed listing of the companies and Long-Term IRs.)

The ratings reflect CNO's balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, neutral business profile and appropriate enterprise risk management.

The affirmation of the ratings is based on the strong assessment of CNO's favorable and consistent operating gains, which draw upon the diversification of its product line offerings across its insurance brands of Washington National, Bankers Life and Colonial Penn. Additionally, the returns from investment income are a strong contributor to the stability of earnings since 2018. These gains have supported a strong assessment of the group's risk-adjusted capital as measured by AM Best's Capital Adequacy Ratio (BCAR) and its regulatory capital. AM Best has observed strong liquidity measures in the group and holding company, where the latest reported cash and cash equivalents at third-quarter 2022 was $498 million. The financial flexibility, also viewed positively by AM Best, is nimble with access to the capital markets through CNO Financial Group, Inc. and the member companies of the group having membership in the Federal Home Loan Banks, which has lent itself to spread lending opportunities.

CNO's business profile is diversified across retirement, life and accident and health insurance offerings. Product sales and distribution are well positioned through CNO's diversified distribution channels including direct-to-consumer, exclusive agents and worksite opportunities. All of this has been accomplished despite CNO operating in a landscape of formidable competition and external pressures that include the strains of selling products during the COVID-19 pandemic. CNO has managed its risks well and has operated and maintained its position within its target markets over the past few years.

The FSR of A (Excellent) and the Long-Term ICRs of "a" (Excellent) have been affirmed with stable outlooks for the following key life/health subsidiaries of CNO Financial Group, Inc.:

The following Long-Term IRs have been affirmed with stable outlooks.

CNO Financial Group, Inc.?
--"bbb" (Good) on $500 million 5.25% senior unsecured notes, due 2025
--"bbb" (Good) on $500 million 5.25% senior unsecured notes, due 2029
--"bbb-" (Good) on $150 million 5.125% subordinated debentures, due 2060

This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2023 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.


These press releases may also interest you

at 09:35
Two large multi-state studies uncovered a highly effective way to improve antibiotic selection for patients hospitalized with pneumonia or urinary tract infections (UTI), enabling better antibiotic stewardship in hospitals, according to research...

at 09:25
The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth analyses of: the scope of telehealth usage in the U.S., telehealth user demographics, pros and...

at 09:00
Amid growing concerns about a medical crisis as a result of acute conflict between the government...

at 08:45
Wolf Haldenstein Adler Freeman & Herz LLP  ("Wolf  Haldenstein") announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern  District of New York on behalf of investors who purchased...

at 08:00
Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, is happy to announce that its wholly owned generic pharmaceutical subsidiary, Nora...

at 07:00
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...



News published on and distributed by: